← Evidence map

ReviewDrugs2018

Andexanet Alfa: First Global Approval.

Young-A HeoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT03988842phase 44 enrolled2019
Full record →Abstract, authors, funding and every citing paper · PMID 29926311